Breast cancer is the second leading cause of cancer deaths in women in the United States. However, clinical advances in screening and treatment paradigms for breast cancer are improving outcomes for these patients. Breast cancer CME and breast cancer CE is essential for clinicians to stay current with these evolving treatment options.
Important recent developments in the treatment paradigm include the optimal adjuvant therapy duration for patients with early breast cancer and the role of newer targeted therapies for advanced breast cancer. In every case, continuing education regarding the optimal use of the available treatment options is critical, including appropriate patient selection, dosing and administration, and best practices for monitoring for adverse events.
Breast cancer CME is essential to the multidisciplinary team of healthcare providers to maintain and increase the clinical skills, knowledge, and professional performance needed to effectively provide high-quality care for patients with this disease.